ARCHIVES

Biomed Research Absent from Bush State of the Union.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987